Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis

Por Coyle, C., Cafferty, F. H., Vale, C., Langley, R. E.
Publicado no Ann Oncol (2016)

Radiation-induced apoptosis in microvascular endothelial cells.

Por Langley, R. E., Bump, E. A., Quartuccio, S. G., Medeiros, D., Braunhut, S. J.
Publicado em 1997

Comment on ‘Endocrine therapy in prostate cancer: time for re-appraisal of risks, benefits and cost-effectiveness?'

Por Shah, S I A, Abel, P D, Langley, R E, Cafferty, F H
Publicado em 2013

Co-enrolment of Participants into Multiple Cancer Trials: Benefits and Challenges

Por Cafferty, F.H., Coyle, C., Rowley, S., Berkman, L., MacKensie, M., Langley, R.E.
Publicado no Clin Oncol (R Coll Radiol) (2017)

Aspirin and cancer: has aspirin been overlooked as an adjuvant therapy?

Por Langley, R E, Burdett, S, Tierney, J F, Cafferty, F, Parmar, M K B, Venning, G
Publicado em 2011

Quality assurance of surgery in the randomized ST03 trial of perioperative chemotherapy in carcinoma of the stomach and gastro‐oesophageal junction

Por Allum, W. H., Smyth, E. C., Blazeby, J. M., Grabsch, H. I., Griffin, S. M., Rowley, S., Cafferty, F. H., Langley, R. E., Cunningham, D.
Publicado no Br J Surg (2019)

Parenteral oestrogen in the treatment of prostate cancer: a systematic review

Por Norman, G, Dean, M E, Langley, R E, Hodges, Z C, Ritchie, G, Parmar, M K B, Sydes, M R, Abel, P, Eastwood, A J
Publicado em 2008

Epstein-Barr virus and mismatch repair deficiency status differ between oesophageal and gastric cancer: A large multi-centre study

Por Hewitt, L.C., Inam, I.Z., Saito, Y., Yoshikawa, T., Quaas, A., Hoelscher, A., Bollschweiler, E., Fazzi, G.E., Melotte, V., Langley, R.E., Nankivell, M., Cunningham, D., Allum, W., Hutchins, G.G., Grabsch, H.I.
Publicado no Eur J Cancer (2018)

Effect of low-dose aspirin use on survival of patients with gastrointestinal malignancies; an observational study

Por Frouws, M A, Bastiaannet, E, Langley, R E, Chia, W K, van Herk-Sukel, M P P, Lemmens, V E P P, Putter, H, Hartgrink, H H, Bonsing, B A, Van de Velde, C J H, Portielje, J E A, Liefers, G J
Publicado no Br J Cancer (2017)

A seven-Gene Signature assay improves prognostic risk stratification of perioperative chemotherapy treated gastroesophageal cancer patients from the MAGIC trial

Por Smyth, E C, Nyamundanda, G, Cunningham, D, Fontana, E, Ragulan, C, Tan, I B, Lin, S J, Wotherspoon, A, Nankivell, M, Fassan, M, Lampis, A, Hahne, J C, Davies, A R, Lagergren, J, Gossage, J A, Maisey, N, Green, M, Zylstra, J L, Allum, W H, Langley, R E, Tan, P, Valeri, N, Sadanandam, A
Publicado no Ann Oncol (2018)

A Repurposing Programme Evaluating Transdermal Oestradiol Patches for the Treatment of Prostate Cancer Within the PATCH and STAMPEDE Trials: Current Results and Adapting Trial Desi...

Por Gilbert, D.C., Nankivell, M., Rush, H., Clarke, N.W., Mangar, S., Al-hasso, A., Rosen, S., Kockelbergh, R., Sundaram, S.K., Dixit, S., Laniado, M., McPhail, N., Shaheen, A., Brown, S., Gale, J., Deighan, J., Marshall, J., Duong, T., Macnair, A., Griffiths, A., Amos, C.L., Sydes, M.R., James, N.D., Parmar, M.K.B., Langley, R.E.
Publicado no Clin Oncol (R Coll Radiol) (2024)

Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial

Por Clarke, N W, Ali, A, Ingleby, F C, Hoyle, A, Amos, C L, Attard, G, Brawley, C D, Calvert, J, Chowdhury, S, Cook, A, Cross, W, Dearnaley, D P, Douis, H, Gilbert, D, Gillessen, S, Jones, R J, Langley, R E, MacNair, A, Malik, Z, Mason, M D, Matheson, D, Millman, R, Parker, C C, Ritchie, A W S, Rush, H, Russell, J M, Brown, J, Beesley, S, Birtle, A, Capaldi, L, Gale, J, Gibbs, S, Lydon, A, Nikapota, A, Omlin, A, O'Sullivan, J M, Parikh, O, Protheroe, A, Rudman, S, Srihari, N N, Simms, M, Tanguay, J S, Tolan, S, Wagstaff, J, Wallace, J, Wylie, J, Zarkar, A, Sydes, M R, Parmar, M K B, James, N D
Publicado no Ann Oncol (2019)